Clinical trials
Phase 1 Lymphoma, B-Cell trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
153 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2004 | 1 |
| 2005 | 2 |
| 2006 | 3 |
| 2007 | 6 |
| 2008 | 1 |
| 2009 | 4 |
| 2010 | 3 |
| 2011 | 4 |
| 2012 | 5 |
| 2013 | 4 |
| 2014 | 3 |
| 2015 | 2 |
| 2016 | 7 |
| 2017 | 8 |
| 2018 | 10 |
| 2019 | 10 |
| 2020 | 13 |
| 2021 | 13 |
| 2022 | 13 |
| 2023 | 17 |
| 2024 | 6 |
| 2025 | 5 |
| 2026 | 8 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 60 |
| Active, not recruiting | 29 |
| Recruiting | 25 |
| Terminated | 23 |
| Withdrawn | 7 |
| Unknown status | 4 |
| Not yet recruiting | 3 |
| Enrolling by invitation | 1 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 16 |
| Mayo Clinic | 5 |
| City of Hope Medical Center | 4 |
| Fate Therapeutics | 4 |
| Fred Hutchinson Cancer Center | 4 |
| Medical College of Wisconsin | 4 |
| University of Pennsylvania | 4 |
| AstraZeneca | 3 |
| M.D. Anderson Cancer Center | 3 |
| Memorial Sloan Kettering Cancer Center | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma, B-Cell | 153 |
| Lymphoma, Non-Hodgkin | 52 |
| Lymphoma, Follicular | 42 |
| Lymphoma, Large B-Cell, Diffuse | 37 |
| Lymphoma, Mantle-Cell | 37 |
| Lymphoma | 34 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 31 |
| Lymphoma, B-Cell, Marginal Zone | 27 |
| Burkitt Lymphoma | 21 |
| Recurrence | 16 |
Trials
Showing 1 to 25 of 153. Each trial links to its page on Pharma Observatory.
53 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.